Thursday, July 12, 2018 -- Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users.
Tuesday, July 17, 2018 -- Researchers identified four patients with a novel hepatitis C genotype, according to study published in The Journal of Infectious Diseases.Despite the genotype’s genetic distinction from previously identified HCV genotypes 1 through 7, all four patients achieved sustained virologic response with direct-acting antivirals.“Seven major genotypes (GTs) have been recognized to date, the complete genomes of which dier from each other by at least 30% at the nucleotide level,” Sergio M. Borgia, MD, FRCP(C), from the Brampton Civic Hospital in Ontario, Canada, and colleagues wrote.
Thursday, July 12, 2018 -- by Benedikt Schaefer, André Viveiros, Ramona Al-Zoairy, Sarah Blach, Samantha Brandon, Homie Razavi, Livia Dorn, Armin Finkenstedt, Maria Effenberger, Ivo Graziadei, Mario Sarcletti, Herbert Tilg, Heinz Zoller Background In 2016, the World Health Organization (WHO) and 69th World Health Assembly approved the first global health sector strategy (GHSS) on viral hepatitis with the goal to eliminate hepatitis C virus (HCV) infections worldwide. The aim is a 90% reduction of new infections and 65% reduction of HCV-related deaths by 2030. Aim This study reports on the epidemiology of HCV infections in the Austrian state of Tyrol (total population 750,000) and uses a predictive model to identify how the WHO strategy for elimination of HCV can be achieved. Methods We developed
Tuesday, July 17, 2018 -- This community-led educate, test-and-treat demonstration project achieved high uptake of HCV testing, linkage to care and treatment, and attainment of cure in one village, as well as awareness and adoption of practices to prevent transmission in the community. This approach could be an important strategy for adoption in rural settings to complement the national government programme towards the elimination of HCV in Egypt.